Roopika K. Menon

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Journal: The Journal of clinical investigation
Published: March 07, 2023

Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes.

Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes.

Journal: Medical sciences (Basel, Switzerland)
Published: March 08, 2022

Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing.

Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing.

Journal: Journal of personalized medicine
Published: May 14, 2021

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer.

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer.

Journal: PloS one
Published: April 25, 2021

ALK alterations in salivary gland carcinomas.

ALK alterations in salivary gland carcinomas.

Journal: Virchows Archiv : an international journal of pathology
Published: August 02, 2020

Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer.

Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer.

Journal: Cancers
Published: April 30, 2020

Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma.

Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 25, 2019

Challenges in the Diagnosis of NTRK Fusion-Positive Cancers.

Challenges in the Diagnosis of NTRK Fusion-Positive Cancers.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 01, 2019

Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.

Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2018

A mechanistic classification of clinical phenotypes in neuroblastoma.

A mechanistic classification of clinical phenotypes in neuroblastoma.

Journal: Science (New York, N.Y.)
Published: March 23, 2018

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients.

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 10, 2017

Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.

Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.

Journal: Cancer discovery
Published: August 22, 2017
Showing 1-12 of 31

Last Updated: 09/26/2026